Genetis is the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA and recombinant vaccines.  Founded by key consortium partners Technovalia, Sypharma and BioNet, Genetis is an independent and fully integrated end-to-end CDMO that combines technology, product development, GMP manufacturing, clinical and regulatory expertise. Genetis offers specialised product development and commercial scale production of mRNA, DNA and recombinant vaccines.